The FoxOs are in the ApoM house
The prevalence of metabolic syndrome continues to increase globally and heightens the risk for cardiovascular disease (CVD). Insulin resistance is a core pathophysiologic mechanism that causes abnormal carbohydrate metabolism and atherogenic changes in circulating lipoprotein quantity and function....
Main Authors: | MacRae F. Linton, Patricia G. Yancey, Zoe M. Leuthner, Jonathan D. Brown |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Clinical Investigation
2022-04-01
|
Series: | The Journal of Clinical Investigation |
Online Access: | https://doi.org/10.1172/JCI158471 |
Similar Items
-
Characterization of apoM in normal and genetically modified mice
by: Kirsten Faber, et al.
Published: (2004-07-01) -
ApoM binds endotoxin contributing to neutralization and clearance by High Density Lipoprotein
by: Hanaa Mousa, et al.
Published: (2023-07-01) -
The apoM/S1P Complex—A Mediator in Kidney Biology and Disease?
by: Line S. Bisgaard, et al.
Published: (2021-10-01) -
Identification of ApoA4 as a sphingosine 1-phosphate chaperone in ApoM- and albumin-deficient mice
by: Hideru Obinata, et al.
Published: (2019-11-01) -
Increased plasma apoM levels in the patients suffered from hepatocellular carcinoma and other chronic liver diseases
by: Li Min, et al.
Published: (2008-07-01)